Solventum Corporation (SOLV) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Solventum Corporation (SOLV:NYSE), powered by AI.

Current Price
$78.87
P/E Ratio
8.8
Market Cap
13.7B
Sector
Healthcare
What is the Solventum Corporation stock price forecast?

Solventum Corporation is currently trading at $78.87. View real-time AI analysis on Alpha Lenz.

What is Solventum Corporation insider trading activity?

View the latest insider trading data for Solventum Corporation on Alpha Lenz.

What is Solventum Corporation's P/E ratio?

Solventum Corporation's P/E ratio is 8.8.

Solventum Corporation

NYSE · SOLV
$78.87-0.35(-0.44%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about Solventum Corporation's future dividend policy...
Alpha Chat Insight

Solventum Corporation trades at a P/E of 8.8 (undervalued) with strong ROE of 38.9%.

Ask for details

Company Overview

Solventum Corporation is a leading American healthcare company that emerged as an independent entity following its spin-off from 3M in April 2024. Built on over 70 years of healthcare innovation, Solventum develops, manufactures, and commercializes solutions aimed at addressing critical needs in the global medical community. The company's operations encompass four primary segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. Solventum's products and services support a diverse array of healthcare applications, from advanced medical and surgical equipment to digital dental solutions and health information systems, impacting both providers and patients. With a workforce exceeding 20,000 professionals and a presence in 38 countries, Solventum operates more than 300 offices and facilities worldwide. The corporation has established itself as a significant force in the global healthcare sector, consistently advancing new technologies and fostering partnerships to improve health outcomes. Solventum emphasizes sustainability, innovation, and addressing healthcare disparities, aiming to create a healthier future. Its substantial scale and diversified healthcare portfolio position it as a critical player in shaping industry standards and supporting the delivery of effective, safer patient care across international markets.

CEOMr. Bryan C. Hanson
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees22,000

Company Statistics

FY 2025

Profile

$13.73BMarket Cap
$8.32BRevenue
0.00Shares Out
22,000Employees

Margins

53.47%Gross
13.00%EBITDA
7.59%Operating
20.58%Pre-Tax
18.69%Net

Valuation

8.82P/E
2.72P/B
1.65EV/Sales
16.53EV/EBITDA
-1373.13P/FCF

Growth (CAGR)

0.79%Rev 3Yr
2.72%Rev 5Yr
-28.00%Op Inc 3Yr
-15.07%Op Inc 5Yr
5.03%Net Inc 3Yr
6.46%Net Inc 5Yr

Returns

10.82%ROA
38.86%ROE
14.33%ROIC

Financial Health

$878.00MCash & Cash Equivalents
$8.37BNet Debt
183.05%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Solventum Corporation (ticker: SOLV) is a company listed on NYSE in the Healthcare sector (Medical Instruments & Supplies). It has approximately 22,000 employees. Market cap is $13.7B.

The current price is $78.87 with a P/E ratio of 8.82x and P/B of 2.72x.

ROE is 38.86% and operating margin is 7.59%. Annual revenue is $8.3B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Solventum Corporation (SOLV) Stock Forecast 2026 $78.87 — Price, Financials & Analyst Targets | Alpha Lenz